Clinical Trial Update: Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating milrinone infusion for cerebral vasospasm after subarachnoid hemorrhage has completed. The snippet does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Subarachnoid Hemorrhage

Drugs mentioned

• Milrinone (milrinone)

Snippet

Sponsor: University Hospital, Angers | Conditions: Vasospasm | Phase 3 | Status: COMPLETED